Dr Andrew Steer presents ‘Group A Streptococcal disease in Fiji’, on Tuesday, 25 September, from 12.30pm to 1.30pm.
Rheumatic fever and rheumatic heart disease, acute post-streptococcal glomerulonephritis, pyoderma and invasive group A streptococcal infections have been identified by local clinicians as important causes of morbidity and mortality in Fiji.
In response to this, and in preparation for potential group A streptococcal vaccine trials, the Fiji Group A Streptococcal Project began a suite of five epidemiologic studies in late 2005 with three aims:
- To determine the burden of group A streptococcal disease in Fiji;
- To describe the molecular epidemiology of group A streptococcal isolates in Fiji; and
- To investigate immune correlates of protection for group A streptococcal vaccines.
Dr Steer’s presentation will provide an overview of preliminary data from these studies with an emphasis on the implications of the results for vaccine development in the developing world.
Dr Andrew Steer is a NHMRC Clinical and Public Health Research Fellow at the Centre for International Child Health, University of Melbourne, Department of Paediatrics.
This seminar takes place in the Menzies Seminar Room, John Mathews Building, Royal Darwin Hospital Campus.
Visit the Menzies School of Health Research website for information about this and future seminars.